Drugs / TAK-329
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01311076 | Mar → Dec 2011 | type 1 diabetes mellitus | Takeda | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAK-329 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01311076 ↗ |
| Route | Oral | “TAK-329 50 mg, tablets, orally, single dose, one day.” NCT01311076 ↗ |